Clinical trial
Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults
NCT00258947 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00258947 |
|---|---|
| Title | Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young Adults |
| Official title | Take Evaluation and Safety of Smallpox Vaccine (LISTER Strain) in Naïve Healthy Adults. |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Smallpox, Poxvirus Infection |
| Intervention type | Biological |
| Interventions | Smallpox vaccine, LISTER strain, from chick embryo cells |
| Enrollment | 230 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Nov 28, 2005 |
| Last update posted | Feb 1, 2012 |
| Countries | France |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: